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Abstract 17 
 Virulence of Yersinia pestis in mammals requires the type III secretion system, 18 
which delivers seven effector proteins into the cytoplasm of host cells to undermine 19 
immune responses. All seven of these effectors are conserved across Y. pestis strains, but 20 
three – YopJ, YopT, and YpkA – are apparently dispensable for virulence. Some degree 21 
of functional redundancy between effector proteins would explain both observations. 22 
Here, we use a combinatorial genetic approach to define the minimal subset of effectors 23 
required for full virulence in mice following subcutaneous infection. We found that a Y. 24 
pestis strain lacking YopJ, YopT, and YpkA is attenuated for virulence in mice, and that 25 
addition of any one of these effectors to this strain increases lethality significantly. YopJ, 26 
YopT, and YpkA likely contribute to virulence via distinct mechanisms. YopJ is uniquely 27 
able to cause macrophage cell death in vitro and to suppress accumulation of 28 
inflammatory cells to foci of bacterial growth in deep tissue, whereas YopT and YpkA 29 
cannot. The synthetic phenotypes that emerge when YopJ, YopT, and YpkA are removed 30 
in combination provide evidence that each enhances Y. pestis virulence, and that YopT 31 
and YpkA act through a mechanism distinct from that of YopJ. 32 
Introduction 33 
Yersinia pestis, causative agent of plague, is notorious for its role in the European 34 
Black Death pandemics of the Middle Ages. Its pathogenesis in the mammalian host is 35 
remarkable: following inoculation of a small number of bacteria in the dermis by the bite 36 
of an infected flea, Y. pestis rapidly invades distal tissues and the vasculature. The 37 
resulting dense bacteremia enhances transmission, as it allows colonization of naïve fleas 38 
that ingest a sub-microliter blood meal. Dissemination of Y. pestis from the dermis to the 39 
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bloodstream requires several bacterial adaptations that work in concert to achieve near-40 
absolute suppression of the innate immune responses that would otherwise contain or 41 
clear the infection. 42 
The Y. pestis type III secretion system (T3SS) is a major contributor to this innate 43 
immune evasion strategy. The T3SS transports bacterial proteins, called effectors, into 44 
the cytoplasm of target eukaryotic cells (1, 2). The bacterial translocon proteins YopB 45 
and YopD form a pore in the host cell membrane and interact with the syringe-like T3SS 46 
“injectisome” apparatus. This assembly is thought to form a continuous conduit that 47 
transports effector proteins directly from the intracellular compartment of the bacterial 48 
cell into the cytosol of target cells (2-4), though some recent data has challenged this 49 
model (5, 6). 50 
The T3SS of the pathogenic yersiniae targets innate immune cells in vivo (7) and 51 
undermines a variety of antimicrobial responses in these cells, including phagocytosis, 52 
immune signaling, and the production of reactive oxygen species (ROS) (reviewed in 53 
(8)). Intoxication of these cells by the T3SS is one of the most important mechanisms 54 
underlying the innate immune evasion that is so crucial for Y. pestis virulence, and 55 
spontaneous loss of the pCD1 plasmid that encodes the T3SS profoundly attenuates Y. 56 
pestis in mammalian infection models (9-11). Mutations that compromise the type III 57 
secretion mechanism by inactivating injectisome components are likewise highly 58 
attenuating (12, 13). 59 
Y. pestis shares a conserved set of seven T3SS effectors with the enteropathogenic 60 
yersiniae Y. enterocolitica and Y. pseudotuberculosis. Four of these effectors – YopH, 61 
YopE, YopK, and YopM – are required for full virulence of Y. pestis in murine infection 62 
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models (14-20), although the attenuation associated with YopM deletion seems to vary 63 
among strains (21). YopH, YopE, and YopM directly target innate immune responses: 64 
YopH and YopE inhibit the production of reactive oxygen species (ROS) (22, 23) and 65 
interfere with phagocytosis (24-27), while YopM likely enhances virulence by preventing 66 
caspase 1 signaling (28, 29) and pyrin inflammasome activation (30, 31). The attenuation 67 
of YopK mutants may result from dysregulated secretion of the other effector proteins 68 
and the translocon proteins (19, 32). 69 
The effector YopJ profoundly deranges host cell death signaling pathways in 70 
vitro, and as a result YopJ has been intensively studied in all three pathogenic Yersinia 71 
species. YopJ induces caspase-8/RIP-1 mediated apoptosis in macrophages, inhibits 72 
transcription of pro-inflammatory cytokines by NFκB, and may also stimulate caspase-1 73 
signaling (33-35). However, Y. pestis mutants lacking the yopJ gene have been shown 74 
more than once to retain full virulence in vivo (36, 37). Single knock-outs of the cysteine 75 
protease YopT and the serine/threonine kinase YpkA have not been reported to impact 76 
virulence of Y. pestis in mammalian infection models.  77 
Although YopJ, YopT, and YpkA are individually dispensable for Y. pestis 78 
virulence, all three effectors are conserved across natural and experimental Y. pestis 79 
strains. Given the small number of T3SS effectors found in Y. pestis, especially compared 80 
with the T3SSs of many other Gram-negative pathogens, it is likely that these effectors 81 
are selectively maintained because they play a role during some stage of the natural Y. 82 
pestis transmission cycle. However, these three effectors share some putative targets with 83 
one another and with the other T3SS effectors at both the protein and pathway level (8). 84 
Their functions may therefore overlap sufficiently to account for the observation that 85 
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single deletion of any one does not have a measurable effect, at least in the context of 86 
standard laboratory survival studies using inbred mouse strains. 87 
Traditional single gene knockout models are ill-suited to studying the individual 88 
contributions of the T3SS effectors, which share a high degree of interconnectedness 89 
among their putative target molecules and pathways. For example, no fewer than four 90 
effectors (YopH, YopE, YpkA, and YopT) are reported to interfere with phagocytic 91 
function of innate immune cells (reviewed in (8)). For this reason, if a mutation in a 92 
single effector fails to yield an attenuation phenotype in vivo, it is difficult to distinguish 93 
between true dispensability of the effector’s function and possible functional redundancy 94 
with other components of the T3SS.  95 
To determine the effects of the YopJ, YopT, and YpkA effectors, we chose 96 
instead to test for gain-of-function phenotypes when effectors were added back to a strain 97 
from which all seven effector proteins had been deleted. This combinatorial genetic 98 
approach focuses on finding synthetic phenotypes, and is therefore robust to functional 99 
redundancy. We were able to dissect the individual contribution of each effector to 100 
pathogenesis in the intact animal. All seven effector proteins enhance virulence in mice – 101 
the first clear demonstration that YopJ, YopT, and YpkA can each contribute to Y. pestis 102 
virulence in vivo. The collection of combinatorial effector knock-outs we generated also 103 
allowed us begin the process of quantifying and characterizing the non-redundant role 104 
that each effector plays during infection. While it seems likely that the contribution of 105 
YopJ results from its effective killing of macrophages, as has been reported, the 106 
mechanisms underlying the contributions of YopT and YpkA remain uncertain despite 107 
considerable knowledge of their biochemical activity. 108 
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Results 109 
Effectors YopH, YopE, YopK, and YopM are not sufficient for full virulence in vivo. 110 
To understand the functional role of each of the Y. pestis T3SS effector proteins during 111 
infection, we set out to find the minimal subset of effectors that were sufficient to 112 
mediate full virulence through the subcutaneous route of infection.  113 
We approached this problem by first constructing KIM1001ΔT3SE, an unmarked 114 
strain that retains the T3SS injectisome, regulatory elements, and translocon proteins, but 115 
carries in-frame deletions in the open reading frames (ORFs) for all seven effector 116 
proteins (see Table S1 for details). This strain, constructed in the fully-virulent 117 
background KIM1001 (38), was highly attenuated through the subcutaneous route of 118 
infection. When infected with 103 CFU KIM1001ΔT3SE, 0 of 8 mice developed visible 119 
symptoms of disease, and all mice survived infection (Table 1). 120 
Functional ORFs for various effectors were restored at their original loci in the 121 
ΔT3SE genetic background to generate strains expressing defined subsets of effectors. 122 
YopH and YopE are more strictly required for bacterial fitness in vivo than any of the 123 
other effector proteins (18). However, we found that these two effectors in combination 124 
are not sufficient for virulence. The strain KIM1001ΔT3SE::+yopHE, expressing YopH 125 
and YopE but carrying in-frame deletions in all of the remaining five effectors’ ORFs, 126 
failed to sicken or kill any mice following subcutaneous infection with 103 CFU (n=10). 127 
By contrast, this dose is uniformly fatal with wild-type KIM1001 (Table 1). 128 
Single deletion studies have demonstrated that YopM and YopK are also essential 129 
for full virulence of Y. pestis (19, 20). However, neither of these effectors was sufficient 130 
to restore virulence in the KIM1001ΔT3SE::+yopHE background. Strains expressing 131 
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only YopH, YopE, and YopM (KIM1001ΔT3SE::+yopHEM) or YopH, YopE, and 132 
YopK (KIM1001ΔT3SE::+yopHEK) remained attenuated (0 out of 6 mice killed for each 133 
group following subcutaneous infection with 103 CFU) (Table 1), though 2 out of 6 mice 134 
infected with KIM1001ΔT3SE::+yopHEK lost their fur around the injection site and 135 
developed local redness of the skin that persisted for at least 28 days. 136 
The KIM1001ΔT3SE::+yopHEKM strain expresses all effectors previously 137 
reported to be necessary for full virulence, as assessed by subcutaneous infection based of 138 
single knockout mutants. This strain was substantially more virulent than the previous 139 
strains expressing subsets of these effectors, but significantly attenuated relative to the 140 
wild-type strain. KIM1001ΔT3SE::+yopHEKM killed approximately 50% of infected 141 
mice (9 out of 17) at a dose of 103 CFU, indicating a ~100-fold increase of LD50 142 
compared to wild-type KIM1001. Simultaneously restoring functional copies of the ypkA, 143 
yopJ, and yopT ORFs to this strain (generating the strain 144 
KIM1001ΔT3SE::+yopHEKMAJT, genetically identical to the wild-type strain 145 
KIM1001) fully complemented its virulence defect, restoring virulence to wild-type 146 
levels as expected.  This result also confirmed that the long series of genetic 147 
manipulations required for sequentially deleting and then restoring the seven effector 148 
genes did not cause unexpected or off-target modifications that alter virulence 149 
phenotypes (Figure 1 and Table 1). 150 
Strains expressing YopK or YopM in addition to YopH and YopE induce more 151 
effective adaptive immunity. The avirulence of strains KIM1001ΔT3SE::+yopHE, 152 
KIM1001ΔT3SE::+yopHEM, and KIM1001ΔT3SE::+yopHEK led us to investigate their 153 
potential as live attenuated vaccines. To assess the degree of protection conferred by 154 
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infection with these strains, surviving mice were challenged 28 days after initial infection 155 
with 103 CFU KIM1001 s.c. Mice exposed to KIM1001ΔT3SE::+yopHEM or 156 
KIM1001ΔT3SE::+yopHEK uniformly survived the challenge, while 3 out of 10 mice 157 
exposed to KIM1001ΔT3SE::+yopHE succumbed within 14 days (Figure 2). The full 158 
protection from challenge conferred by KIM1001ΔT3SE::+yopHEK and 159 
KIM1001ΔT3SE::+yopHEM suggests that each of these strains, while nonlethal, causes 160 
infection that is sufficiently persistent to trigger robust involvement of the adaptive 161 
immune system. The partial protection provided by exposure to 162 
KIM1001ΔT3SE::+yopHE indicates a weaker or less consistent adaptive immune 163 
response, suggesting that this strain is more susceptible to clearance by the innate 164 
immune system. 165 
YopJ, YopT, and YpkA each contribute to virulence of Y. pestis following 166 
subcutaneous infection. The attenuation of KIM1001ΔT3SE::+yopHEKM relative to 167 
KIM1001ΔT3SE::+yopHEKMAJT is strong evidence that at least one of the remaining 168 
effectors (YopT, YpkA, or YopJ) functionally contributes to virulence in vivo. However, 169 
strains deficient in any one of these effectors are not significantly attenuated (36, 37) (and 170 
see Table 1). 171 
We generated derivatives of the KIM1001ΔT3SE::+yopHEKM strain that 172 
included a functional copy of either the ypkA, yopT, or yopJ gene in its original locus. 173 
The resulting strains were KIM1001ΔT3SE::+yopHEKMA, expressing YpkA; 174 
KIM1001ΔT3SE::+yopHEKMT, expressing YopT; and KIM1001ΔT3SE::+yopHEKMJ, 175 
expressing YopJ. Each of these strains was substantially more virulent than 176 
KIM1001ΔT3SE::+yopHEKM. Although none caused 100% mortality, each was virulent 177 
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enough that the difference between survival curves for these strains and the wild-type 178 
strain KIM1001 was not statistically significant (Figure 3 and Table 1). Given the distinct 179 
biochemical activities of YopT, YpkA, and YopJ, it is curious that each of these effectors 180 
increased virulence of the KIM1001ΔT3SE::+yopHEKM approximately equally. The 181 
different targets and activities reported for these effectors suggest that they are not truly 182 
redundant at the molecular level, and may therefore enhance virulence through distinct 183 
processes. 184 
YopJ suppresses immune cell recruitment in the liver. Evaluation of liver pathology 185 
following intravenous infection is a useful method to assay immune cell responses to Y. 186 
pestis (21, 39, 40). KIM1001ΔT3SE::+yopHEKM and the strains that additionally 187 
expressed YpkA, YopT, or YopJ were injected intravenously into mice. Livers were 188 
collected 48 hours after infection for histopathological analysis. 189 
KIM1001ΔT3SE::+yopHEKM elicited robust recruitment of immune cells, whereas 190 
KIM1001ΔT3SE::+yopHEKMAJT, like KIM1001, effectively suppressed accumulation 191 
of inflammatory cells at foci of bacterial growth (Figure 4A-B). The addition of YopJ to 192 
KIM1001ΔT3SE::+yopHEKM appears sufficient to fully suppress immune cell 193 
recruitment in this context, as lesions caused by KIM1001ΔT3SE::+yopHEKMJ were 194 
indistinguishable from those caused by KIM1001. By contrast, neither 195 
KIM1001ΔT3SE::+yopHEKMA nor KIM1001ΔT3SE::+yopHEKMT suppressed 196 
inflammatory cell recruitment relative to KIM1001ΔT3SE::+yopHEKM (Figure 4A-B). 197 
YopJ, therefore, appears to be uniquely essential (though likely not sufficient) for 198 
suppressing accumulation of immune cells at sites of bacterial replication in vivo. 199 
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YpkA and YopT are dispensable for inducing macrophage cell death and for 200 
bacterial survival in co-culture with neutrophils. The ability of the Y. pestis T3SS to 201 
cause apoptosis in macrophages is well established, and is considered an important 202 
function in promoting virulence. We therefore examined how various combinations of 203 
effectors influenced cell death of immortalized macrophages in vitro. 204 
Some incomplete sets of Yersinia effectors result increased macrophage death, 205 
either via YopE induction of pyroptosis (30, 31) or as a result of dysregulated effector 206 
and translocon secretion in the absence of YopK (32, 41). However, the 207 
ΔT3SE::+yopHEKM strain expresses both YopM, which prevents YopE-mediated 208 
activation of the pyrin inflammasome (30, 31), and YopK, which prevents inflammasome 209 
activation by translocon components (41, 42). As expected, therefore, this strain resulted 210 
in minimal macrophage death (Figure S1). 211 
Consistent with previous reports (21, 43, 44), we observed T3SS-dependent cell 212 
death induced by YopJ. The ΔT3SE::+yopHEKMJ strain caused macrophage death at a 213 
level indistinguishable from the wild-type strain (Figure S1). This YopJ-mediated cell 214 
death may contribute to the reduced visible recruitment of innate immune cells in vivo 215 
(Figure 4). Addition of YopT or YpkA to a strain expressing YopE, YopH, YopK, and 216 
YopM had no effect on macrophage cell death. 217 
 In addition to undermining macrophage function, Y. pestis must overcome the 218 
antimicrobial host responses mediated by neutrophils. The T3SS is known to be critical 219 
for evasion of neutrophil killing in vitro (45) (and, to some degree, in vivo (20)). To 220 
determine whether any of the observed synthetic phenotypes in vivo result from 221 
differential ability to survive neutrophil antimicrobial responses, effector mutants were 222 
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assayed systematically for the ability to survive in co-culture with primary human 223 
neutrophils. To facilitate the effort of assaying a large number of bacterial strains 224 
simultaneously, we developed a luminescence-based assay to monitor bacterial survival 225 
in co-culture with human neutrophils that is higher-throughput than plating to measure 226 
colony-forming units (CFU), and has the additional benefit of providing a readout of 227 
bacterial metabolic activity in real time (see Methods). Survival of Y. pestis in co-culture 228 
with neutrophils required the T3SS, as expected (Figure S2). The T3SS injectisome in 229 
combination with either YopH or YopE is sufficient for this survival phenotype (Figure 230 
S3A), and deletion of both YopH and YopE together recapitulates the susceptibility to 231 
neutrophils observed in a T3SS-deficient strain (Figure S3B). No other effector is 232 
necessary (Figure S4) or sufficient (Figure S5) for bacterial survival in the presence of 233 
primary neutrophils in vitro. YopT and YpkA, therefore, are unlikely to enhance 234 
virulence in vivo by directly undermining neutrophil bactericidal activity. 235 
Discussion 236 
Since the original discovery of the type III secretion system in Y. pestis and Y. 237 
pseudotuberculosis (1, 46, 47), type III secretion systems have been found to contribute 238 
to virulence not only in the Yersiniae but also in diverse Gram-negative pathogens, 239 
including pathogenic species of Salmonella, Pseudomonas, Vibrio, Burkholderia, and in 240 
enteropathogenic Escherichia coli strains (48-54). Multifactorial virulence determinants 241 
such as these T3SSs are crucial factors in allowing fulminant pathogens to undermine 242 
host defense systems. However, complex bacterial systems are difficult to study using 243 
traditional single-knockout methods of analysis, which are confounded by apparent 244 
functional redundancy.  245 
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In this work, we used a gain-of-function approach to determine that the four 246 
effectors previously known to be required during infection – YopH, YopE, YopK, and 247 
YopM – are not sufficient to mediate full virulence of Y. pestis. Indeed, strains expressing 248 
only YopH, YopE, and either YopK or YopM failed to sicken or kill any mice, although 249 
infection with these strains is protective against subsequent challenge with virulent Y. 250 
pestis. As these strains retain the structural components of the T3SS, as well as all other 251 
non-T3SS virulence factors, they may prove to useful in the construction of live 252 
attenuated vaccines. 253 
YopJ, YopT, and YpkA had not been shown to contribute uniquely to Y. pestis 254 
virulence in mammalian infection (36, 37) (and see Table 1). We initially suspected that 255 
the apparent dispensability of these effectors was due to functional redundancy between 256 
two of them, but we found instead that all three individually increase virulence when 257 
introduced to the attenuated strain expressing only YopH, YopE, YopK, and YopM. It is 258 
possible that the action of each of these three effectors contributes additively to virulence 259 
of Y. pestis, and that addition of any of them to the core effector set of YopH, YopE, 260 
YopK, and YopM is sufficient to pass some threshold of immune subversion that allows 261 
robust dissemination and proliferation of Y. pestis in vivo. 262 
 YopJ, YopT, and YpkA increase lethality approximately equally, but have 263 
different biochemical activities and targets from one another. Strains expressing each of 264 
these effectors also behave differently in more targeted assays, supporting the model that 265 
these effectors contribute to pathogenesis independently rather than redundantly. For 266 
example, addition of YopJ to the KIM1001ΔT3SE::+yopHEKM construct blocks 267 
accumulation of inflammatory cells at foci of infection in deep tissue, while addition of 268 
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either YopT or YpkA to KIM1001ΔT3SE::+yopHEKM does not produce any obvious 269 
histological signature (Figure 4). This is consistent with a recent finding by our 270 
colleagues Ratner et al., who report a similar phenotype in a YopJ single deletion strain 271 
(21). Ratner et al. also demonstrate that, when YopM is absent, YopJ is necessary for full 272 
virulence of Y. pestis following subcutaneous infection. The YopM-independent role for 273 
YopJ in virulence that we report here is a novel finding. 274 
Although we have now established a functional role for YopT and YpkA in 275 
infection, we cannot yet explain how these effectors enhance the virulence of the 276 
KIM1001ΔT3SE::+yopHEKM strain. T3SS induction of macrophage cell death, while 277 
important for Y. pestis pathogenesis, does not appear to require either of these effectors. 278 
The work presented here is in agreement with reports that, though NLRP3/NLRC4-279 
mediated cell death has been shown to occur in response to the needle and translocon 280 
proteins of the JG150ΔT3SE strain (21, 44), macrophage cell death mediated by the wild-281 
type T3SS seems to depend primarily on the activity of YopJ (34, 43). The T3SS of Y. 282 
pestis also targets neutrophils in vivo (7, 20, 55), and neutrophils are key players in 283 
controlling Y. pestis infection (20, 56, 57). However, our work in Y. pestis attributes anti-284 
neutrophil activity primarily to YopH and YopE (Figures S3-S5), consistent with 285 
previous work focusing on Y. pseudotuberculosis and Y. enterocolitica (22, 23, 58-60). 286 
  Interestingly, both YopT and YpkA interfere with Rho signaling in mammalian 287 
cells. YopT is a cysteine protease that cleaves the prenylated moiety from small GTPases 288 
of the Rho family, including RhoA and Rac1, to reduce their activity by releasing them 289 
from the cytoplasmic membrane (61). In Y. pseudotuberculosis, YopT also inhibits RhoG 290 
via this mechanism. This activity synergizes with YopE inhibition of RhoG to decrease 291 
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phagocytic uptake of Yersinia (62). YopT of Y. enterocolitica upregulates transcription of 292 
the anti-inflammatory GILZ protein in HeLa cells and in a monocyte cell line (63), 293 
though whether this is conserved in Y. pestis and functional during infection is unknown. 294 
Like YopT, YpkA inhibits Rho GTPases including RhoA, Rac1, and Rac2 (summarized 295 
in (8)). Rho GTPases are also key host targets of YopE activity. The importance of 296 
multiple effectors for deranging Rho signaling is not clear, though it is possible that 297 
differential tissue tropism or effector kinetics may play a role. Future work with the set of 298 
strains we report here may provide clues regarding the function of YopT and YpkA 299 
during infection. Promising lines of inquiry include measuring the effect of these 300 
effectors on cytokine production in vivo, on the kinetics of distal organ colonization 301 
following subcutaneous infection, and on the ability of Y. pestis to establish and maintain 302 
sufficient bacteremia to reliably infect fleas feeding on infected mammals. 303 
In addition to refining the model of Y. pestis pathogenesis and creating genetic 304 
tools that will streamline further study of this T3SS in the yersiniae, this work represents 305 
a general strategy for effective and efficient genetic analysis of complex bacterial systems 306 
by unmasking the functional contributions of individual components. Genetic analysis of 307 
partially redundant systems, even those of only moderate complexity such as the seven 308 
effectors of the Yersinia T3SS, is difficult to perform in a comprehensive manner. 309 
Combinatorial knockouts are the traditional approach to identifying functional 310 
redundancy, but an unbiased combinatorial approach rapidly becomes unfeasible as the 311 
size of the system increases. For example, even constructing and assaying all 21 possible 312 
double knockouts of Y. pestis T3SS effectors is not an attractive approach, and there is no 313 
guarantee that functional redundancy is limited to only two effectors. The “bottom-up” 314 
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approach we describe here, to identify effector(s) that are sufficient rather than necessary 315 
for various phenotypes, is perhaps generalizable to other complex systems. We have 316 
shown that this approach can be particularly effective when combined with candidate-317 
based hypothesis testing, as this limits the number of combinations that must be 318 
examined. Once such strains are generated, they can be assayed for multiple phenotypes 319 
in both in vitro and in vivo systems. These strain banks, therefore, allow for rapid 320 
systematic identification and disentanglement of apparent functional redundancy among 321 
components of complex bacterial systems. 322 
Materials and methods 323 
Bacterial strains and growth conditions. The genotype and source for Y. pestis strains 324 
are presented in Table S1. Genotype information includes the codons removed by each 325 
in-frame effector deletion: for example, the notation yopHΔ3-467 denotes that the yopH 326 
gene harbors an in-frame deletion of codons 3-467 (inclusive). In vivo experiments 327 
(lethality, liver histology) were performed using strains made in the fully virulent 328 
KIM1001 background. In vitro experiments (macrophage cell death and bacterial survival 329 
in the presence of neutrophils) were performed in the JG150 background (equivalent to 330 
KIM5), which lacks the pgm locus required for iron acquisition, to permit 331 
experimentation under biosafety level 2 conditions. 332 
Y. pestis was cultured in the rich medium TB, prepared to maximize plating 333 
efficiency as previously described (64), or in the defined Serum Nutritional Medium 334 
(SNM) (18). All Y. pestis cultures were supplemented with 2.5 mM CaCl2 to suppress 335 
type III secretion. E. coli strains used in construction of Y. pestis mutants were cultured in 336 
Luria broth. Media were supplemented with 100 μg/ml ampicillin and/or 25 μg/ml 337 
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diaminopimelic acid as appropriate. Y. pestis strains are available on request to 338 
researchers with qualifying regulatory approvals (contact: 339 
Megan.Proulx@umassmed.edu). 340 
Construction and complementation of nonpolar mutant strains of Y. pestis. Y. pestis 341 
mutants were constructed via allelic exchange with the suicide vector pRE107 ((65), gift 342 
from D. Schifferli). Primers are listed in Table S2. Deletion mutants for each gene were 343 
constructed by amplifying flanking homology to the gene using primer pairs A+B and 344 
C+D, hybridizing the resulting fragments, and cloning this “stitched” product into the 345 
pRE107 plasmid before proceeding with allelic exchange as described (65). The E. coli 346 
donor strain β2155 ((66), gift from B. Akerley) was used to propagate pRE107 347 
derivatives and to introduce them into Y. pestis by conjugation. Complementation of 348 
effector mutants was performed in situ, using pRE107-based allelic exchange to replace 349 
each deleted gene with a wild-type copy amplified using the primer pair A+D for each 350 
gene. Attenuated mutants for use in in vitro assays were generated by screening for 351 
spontaneous loss of the pgm locus on HIB agar with Congo Red, verified by PCR as 352 
described (21). Luminescent derivatives were constructed by electroporation of the 353 
pML001 plasmid containing the lux operon from Photorhabdus luminescens (67) 354 
followed by selection of transformants on media supplemented with ampicillin. 355 
Animal infections. All animal infections were conducted in conformity with the Guide 356 
for the Care and Use of Laboratory Animals of the National Institutes of Health, and with 357 
the review and approval of the UMass Medical School Institutional Animal Care and Use 358 
Committee (IACUC). C57BL/6 mice were infected as indicated. All bacterial cultures 359 
used for inoculation were grown at 37°C on TB agar (TB medium with 1.5% agar) 360 
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containing 2.5 mM CaCl2 for one overnight prior to infection. Bacterial cells were diluted 361 
in infection-grade phosphate-buffered saline (PBS) to the desired concentration. In every 362 
case, the number of viable bacteria present in each dose was verified by dilution plating 363 
of the inoculum. Mice were monitored every twelve hours for signs of illness such as 364 
ruffled fur, shallow breathing, limping, reluctance to move, and swollen lymph nodes. 365 
Histological analysis of T3SS mutants in liver tissue. Mice were sacrificed 48 hours 366 
following intravenous infection with 103 CFUs. Livers were removed, fixed in 10% 367 
neutral-buffered formalin, and embedded in paraffin for sectioning and staining. Samples 368 
were randomized and 10 lesions from each mouse were scored, blinded, for severity of 369 
inflammation in bacterial lesions. The following scale was used for scoring: 1 = free 370 
bacteria with few or no inflammatory cells; 2 = some inflammatory cells present, but free 371 
bacteria fill the majority of the lesion area; 3 = lesion area is split approximately equally 372 
between inflammatory cells and bacteria; 4 = some free bacteria are visible, but 373 
inflammatory cells fill the majority of the lesion area; 5 = abundant inflammatory cells 374 
with few or no visible free bacteria. Scoring was performed twice on scrambled, blinded 375 
samples to ensure results were consistent. 376 
Macrophage cell death experiments. Macrophages were monitored for cell death by 377 
ethidium homodimer (EthD1) fluorescence, as described (21). Briefly, 8x104 378 
immortalized murine macrophages from C57BL/6 mice (a gift from K. Fitzgerald) were 379 
infected with 8x104 CFU of various Y. pestis strains grown to mid-log phase in SNM 380 
supplemented with 2.5 mM CaCl2. Macrophages and bacteria were added to flat-381 
bottomed 96-well plates with black sides in DMEM supplemented with 10% ΔFBS, 10 382 
mM HEPES, and 2 μM ethidium homodimer. Plates were centrifuged at 400 rpm for five 383 
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minutes, sealed, and incubated at 37°C in a Synergy H4 microplate reader to monitor 384 
ethidium homodimer fluorescence (645 nm emission, 530 nm excitation). Ethidium 385 
homodimer uptake data was analyzed by calculating the area under the curve (AUC) for 386 
the increasing fluorescence signal and subtracting the AUC of control wells containing 387 
uninfected macrophages. 388 
Survival of T3SS in co-culture with primary human neutrophils. Viability assays 389 
were performed with bioluminescent Y. pestis strains using the plasmid pML001, which 390 
encodes the lux operon from Photorhabdus luminescens (67). Luminescence from this 391 
system requires the reduced flavin mononucleotide FMNH2 as a cofactor (68). As 392 
reduced FMNH2 is rapidly depleted if metabolism or the cell membrane is disrupted, 393 
bioluminescence in this system serves as a proxy for determining viability of the bacterial 394 
population in real time. CFU plating confirmed that the decreased luminescence of a 395 
T3SS-deficient strain after 4 hours in the presence of neutrophils (Figure S2) 396 
corresponded to a 50-80% reduction in bacterial viability compared to the media-only (no 397 
neutrophil) condition. 398 
Whole blood was collected from healthy adult human volunteers in compliance 399 
with protocols reviewed and approved by the University of Massachusetts Medical 400 
School Institutional Review Board (IRB). Neutrophils were isolated from whole blood on 401 
a gelatin gradient as described (69). Y. pestis viability assays were performed in opaque 402 
white flat-bottomed 96-well plates that were coated for 1 hour with 10 μg/mL fibrinogen 403 
in phosphate-buffered saline (PBS) and washed twice with PBS. 5x105 neutrophils were 404 
infected with luminescent strains of Y. pestis at MOI 0.1 in SNM supplemented with 2.5 405 
mM CaCl2, 100 μg/ml ampicillin, and 4% normal human serum. Plates were centrifuged 406 
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at 400 rpm for five minutes, sealed, and incubated at 37°C in a Synergy H4 microplate 407 
reader. Bacterial luminescence was monitored in for six hours. Three independent 408 
bacterial cultures were assayed for each Y. pestis strain in each experiment, and 409 
experiments were performed at least twice with neutrophils from different donors.  410 
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Table 1 422 
 423 
Virulence of Y. pestis strains expressing subsets of type III secretion effector 424 
proteins. All infection experiments were performed with a subcutaneous dose of 1x103 425 
CFU in C57BL/6 mice. Median time to death references only those mice within each 426 
group that succumbed to infection; any mice that survived the duration of the experiment 427 
were excluded from the calculation of this metric. Significance was calculated for each 428 
curve compared to the KIM1001 curve by the Mantel-Cox test. 429 
  430 
Strain Percent lethality 
(number of mice 
killed/total number 









KIM1001ΔT3SE 0% (0/8) NA < 0.0001 
KIM1001ΔT3SE::+yopHE 0% (0/10) NA < 0.0001 
KIM1001ΔT3SE::+yopHEM 0% (0/6) NA < 0.0001 
KIM1001ΔT3SE::+yopHEK 0% (0/6) NA < 0.0001 
KIM1001ΔT3SE::+yopHEKM 53% (9/17) 9 < 0.0001 
KIM1001ΔT3SE::+yopHEKMA 88% (14/16) 6 0.1305 
KIM1001ΔT3SE::+yopHEKMT 87% (13/15) 6 0.1184 
KIM1001ΔT3SE::+yopHEKMJ 85% (22/26) 5.5 0.1031 
KIM1001ΔT3SE::+yopHEKMJT 100% (5/5) 7 0.1501 
KIM1001ΔT3SE::+yopHEKMAJ 100% (5/5) 7 0.4756 
KIM1001ΔT3SE::+yopHEKMAT 80% (4/5) 7 0.1206 
KIM1001ΔT3SE::+yopHEKMAJT 100% (15/15) 5 0.3890 
KIM1001 100% (12/12) 4.5 NA 
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YopH, YopE, YopK, and YopM are not sufficient for full virulence. Subcutaneous 437 
infection with 1000 CFU KIM1001 (w.t.) (n=12), KIM1001ΔT3SE::+yopHEKMAJT 438 
(complemented) (n=15), or KIM1001ΔT3SE::+yopHEKM (+yopHEKM) (n=17). Mice 439 
infected with KIM1001 or with the fully complemented strain rapidly succumbed to 440 
infection, while KIM1001ΔT3SE::+yopHEKM killed 9 out of 17 mice with delayed 441 
kinetics.  442 
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Protective immunity from exposure to Y. pestis mutants expressing subsets of T3SS 449 
effectors. When challenged with 1000 CFU KIM1001 28 days after initial infection, 450 
mice exposed to KIM1001ΔT3SE::+yopHEM and KIM1001ΔT3SE::+yopHEK were 451 
fully protected (n=6 mice each), while exposure to KIM1001ΔT3SE::+yopHE provided 452 
partial protection (3 of 10 mice died). Naïve mice succumbed to infection within seven 453 
days (n=8).  454 
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Figure 3 455 
 456 
Addition of YpkA, YopT, or YopJ enhances the virulence of a Y. pestis strain 457 
expressing YopH, YopE, YopK, and YopM. Survival following subcutaneous infection 458 
with 1000 CFU KIM1001ΔT3SE::+yopHEKMA (+yopHEKMA) (n=16), 459 
KIM1001ΔT3SE::+yopHEKMT (+yopHEKMT) (n=15), or 460 
KIM1001ΔT3SE::+yopHEKMJ (+yopHEKMJ) (n=26), compared to the survival curves 461 
for KIM1001ΔT3SE::+yopHEKMAJT (complemented) and 462 
KIM1001ΔT3SE::+yopHEKM (+yopHEKM) from Figure 1. 463 
KIM1001ΔT3SE::+yopHEKMA killed 14 out of 16 mice, 464 
KIM1001ΔT3SE::+yopHEKMT killed 13 out of 15 mice, and 465 
KIM1001ΔT3SE::+yopHEKMJ killed 22 out of 26 mice, all with kinetics similar to 466 
KIM1001ΔT3SE::+yopHEKMAJT.  467 
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Figure 4 468 
 469 
YopJ suppresses immune cell recruitment to foci of bacterial growth in liver tissue. 470 
(A) Representative liver sections stained with hematoxylin and eosin from mice 48 hours 471 
after intravenous infection with 103 CFU KIM1001 (w.t.), 472 
KIM1001ΔT3SE::+yopHEKMAJT (complemented), KIM1001ΔT3SE::+yopHEKMJ 473 
(+yopHEKMJ), KIM1001ΔT3SE::+yopHEKM (+yopHEKM), 474 
KIM1001ΔT3SE::+yopHEKMA (+yopHEKMA), or KIM1001ΔT3SE::+yopHEKMT 475 
(+yopHEKMT). Strains with a functional yopJ allele grow freely in liver tissue without 476 
attracting inflammatory cells (top row), in contrast to strains deficient in yopJ (bottom 477 
row). (B) Severity of inflammation was scored on an arbitrary scale (1 = free bacteria 478 
with few or no inflammatory cells; 5 = abundant inflammatory cells with little or no 479 
visible free bacteria). Each data point represents the average score for 10 lesions from a 480 
single mouse. Representative of two independent blinded scorings.  481 
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